Harnessing the power of fully human domain antibody (UDAB™)to fight disease: At Biomissile, we discover and develop multi-specific therapeutic antibodies to fight a wide range of diseases, especially in areas where there are no effective therapies.
Read More
A therapeutic pipeline of more than 10 innovative
biologics, including several first-in-class fully human
domain antibody-based bi- and multi-specifics
(UDAB-MTM).
To become a premium innovative biopharmaceutical company based on our unique platform technologies, strong pipeline, and outstanding team.
Suzhou: GMP
Shanghai: Discovery
Boston: BD & Regulatory
